Nika Pharmaceuticals, Inc
NIKA· OTC
NIKANika Pharmaceuticals, Inc
Filed Aug 21, 2023 · 10-Q · 52 days after period end · 0001826466-23-000031
| Metric | Q2 2023 | Q2 2022 | Q2 2021 |
|---|---|---|---|
| Revenue | $0.00 | $0.00 | — |
| Net Income | -$27.81K | $3.16M | -$2.96K |
| EPS Diluted | $0.00 | $0.00 | $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Nika Pharmaceuticals, Inc · CIK 1145604 · Engraved from SEC EDGAR
ended Jun 30, 2023 · filed Aug 21, 2023 · 52 d after period end
